Recent years have witnessed significant advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as promising https://flynnrddd050070.weblogco.com/39202082/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide